Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).
EClinicalMedicine
; 40: 101116, 2021 Oct.
Article
em En
| MEDLINE
| ID: mdl-34522873
APRI, AST to platelet ratio index; ART, antiretroviral treatment; AST, aspartate aminotransferase; BMI, body mass index; CAP, controlled attenuation parameter; Cap; DAA, direct-acting antiviral; FAST, FibroScan-AST; FIB4, fibrosis-4; HCV, chronic hepatitis C; Hiv; INSTI, integrase strand transfer inhibitors; NAFLD, Non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; Nafld; PLHIV, people living with HIV; PrEP, pre-exposure prophylaxis; Steatosis; TAF, tenofovir-alafenamid; TDF, Tenofovir disoproxilfumarate; TE, transient elastography; cART
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Idioma:
En
Revista:
EClinicalMedicine
Ano de publicação:
2021
Tipo de documento:
Article